OpenAlex
PricingAboutJobs
Log inGet started
Work

Stratégie d’arrêt du dupilumab dans la pemphigoïde bulleuse : étude multicentrique rétrospective de 144 patients

HTML

Year: 2026
Type: article
Study design: Observational Study
Source: Annales de Dermatologie et de Vénéréologie - FMC
DOI: 10.1016/j.fander.2026.09.090
Authors: R. Gabriel, P. Moghadam, E. Tancrede-Bohin, E. Charvet, S. Oro, J.D. Bouaziz, C. Berthin, E. Brenaut, A. Brue, A. Clément, J. El Khalifa, M. Chastagner, C. Saillard, I. Gallais-Sérézal, A. Lefebvre, V. Hébert, M. Marcaillou, A. Pham-Ledard, F. Lombart, S. Duvert Lehembre, C. Bedane, M.P. Konstantinou, A. Dangien, G. Bohelay, E. Le Bidre, S. Mallet, G. Quéreux, S. Fourmond, M. Tardieu, C. Le Roux-Villet, M. Alexandre-Audaire, S. Debarbieux, M. Aymonier, N. Beneton, T. Bettuzzi, C. Lepelletier
Language: French

Topic: Autoimmune Bullous Skin Diseases
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Keywords: dupilumab, bullous pemphigus, treatment withdrawal, relapse, steroid-sparing therapy, long-term follow-up, complete remission, IL-4 receptor alpha, IL-13 receptor alpha, IL-10 receptor alpha, IL-12/23
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W7225792011
FWCI:
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security